DUBLIN–(BUSINESS WIRE)–The “Piroxicam (CAS 36322-90-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report on Piroxicam provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves … [Read more…]

AI-Powered Multimodal Profiling Accelerates Mechanism Discovery, Patient Stratification and Biomarker-Driven Therapeutic Development in Hematologic Malignancies WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced the selection of two abstracts for oral presentation, three abstracts for poster presentation and one abstract for online publication at the 67th American Society of … [Read more…]

TORONTO–(BUSINESS WIRE)–Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that it will participate in the following investor conferences: Piper Sandler 37th Annual Healthcare Conference (New York, NY) Date: Wednesday, Dec. 3, 2025 Time: 12:50 p.m. ET Format: Presentation … [Read more…]

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate … [Read more…]

CHICAGO–(BUSINESS WIRE)–The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the fourth quarter of 2025 payable on February 13, 2026, to all shareholders of record as of January 9, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a trusted … [Read more…]

MOUNT ROYAL, N.J.–(BUSINESS WIRE)–#AHSAZ–The American Headache Society® (AHS), a professional society of healthcare providers dedicated to the study and treatment of headache and face pain, will host the 2025 Scottsdale Headache Symposium December 4-7 in Scottsdale, Arizona. This year’s meeting brings together physicians, scientists, and advanced practitioners for an immersive educational experience designed to elevate … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Phenindione (CAS 83-12-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report on Phenindione provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves … [Read more…]

Elevance Health is making healthcare more intuitive and personalized using technology to simplify access and build trust. Elevance Health’s affiliated health plans are building loyalty through connection and ongoing support. Digital tools address member pain points by providing clear, accurate, and personalized information. INDIANAPOLIS–(BUSINESS WIRE)–Saurabh Tandon, Elevance Health’s chief experience officer, shared his thoughts on … [Read more…]

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that, following the conclusion of the American Society of Hematology (ASH) Annual Meeting and Exposition, the company will hold a virtual investor event on Thursday, December 11, 2025, to highlight key Hematology programs. The company will host a webcast beginning at 9:00 a.m. ET, which is … [Read more…]

Poxel’s recovery plan has been finalised: Main objectives: accelerating commercial development and partnership-seeking activities for Imeglimine outside Japan, PXL 770 and PXL 065, significantly reducing the Company’s costs, and clearing the Company’s liabilities. It was developed with the support of its long-standing financial partner IPF. IPF and IRIS have committed to providing the Company with … [Read more…]